Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

Intellia Therapeutics is featured in Cathie Wood's portfolio and has a high Wall Street price target. The company's leading candidates look somewhat promising, but one of them just hit a major setback ...

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

The total market value of ALL pharma and biotech companies is $4.6 trillion.

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

Companies working on new medicines to treat obesity and a new approach to using artificial intelligence in science labs are ...

The Swiss drugmaker on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash ...

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...